Notably, the average expression level of ANT3 in all hematological malignancies included in the database, including myeloid leukemia, lymphoma, and myeloma cell lines, ranked at the forefront of all tissue-derived tumors. Here, SLC25A6 is linked to plasma cell myeloma.